Capstone Investment Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $779K | Sell |
6,472
-25,432
| -80% | -$2.94M | ﹤0.01% | 953 |
|
|
2025
Q4 | $3.36M | Sell |
31,904
-73,974
| -70% | -$6.94M | 0.01% | 470 |
|
|
2025
Q3 | $8.89M | Sell |
105,878
-1,612
| -1% | -$133K | 0.02% | 338 |
|
|
2025
Q2 | $8.51M | Sell |
107,490
-7,336
| -6% | -$583K | 0.02% | 282 |
|
|
2025
Q1 | $10.3M | Sell |
114,826
-19,155
| -14% | -$1.79M | 0.03% | 294 |
|
|
2024
Q4 | $13.3M | Buy |
133,981
+106,360
| +385% | +$11M | 0.03% | 297 |
|
|
2024
Q3 | $3.14M | Buy |
27,621
+11,694
| +73% | +$1.39M | 0.01% | 589 |
|
|
2024
Q2 | $1.97M | Buy |
+15,927
| New | +$2.05M | 0.01% | 728 |
|
|
2023
Q4 | – | Sell |
-24,163
| Closed | -$2.51M | – | 2285 |
|
|
2023
Q3 | $2.49M | Buy |
24,163
+23,104
| +2,182% | +$2.49M | 0.01% | 651 |
|
|
2023
Q2 | $122K | Sell |
1,059
-5,369
| -84% | -$610K | ﹤0.01% | 1663 |
|
|
2023
Q1 | $684K | Buy |
6,428
+5,000
| +350% | +$540K | ﹤0.01% | 909 |
|
|
2022
Q4 | $158K | Buy |
1,428
+1,185
| +488% | +$121K | ﹤0.01% | 1341 |
|
|
2022
Q3 | $21K | Sell |
243
-24,548
| -99% | -$2.19M | ﹤0.01% | 1625 |
|
|
2022
Q2 | $2.26M | Buy |
24,791
+213
| +0.9% | +$18.9K | 0.01% | 715 |
|
|
2022
Q1 | $2.02M | Buy |
24,578
+23,939
| +3,746% | +$1.89M | 0.01% | 1044 |
|
|
2021
Q4 | $49K | Sell |
639
-145,777
| -100% | -$11.6M | ﹤0.01% | 1730 |
|
|
2021
Q3 | $11M | Buy |
+146,416
| New | +$11.1M | 0.02% | 592 |
|
|
2021
Q2 | – | Sell |
-125,368
| Closed | -$9.32M | – | 1805 |
|
|
2021
Q1 | $9.22M | Buy |
125,368
+78,802
| +169% | +$5.81M | 0.03% | 482 |
|
|
2020
Q4 | $3.63M | Buy |
46,566
+45,800
| +5,979% | +$3.5M | 0.01% | 700 |
|
|
2020
Q3 | $61K | Buy |
+766
| New | +$60K | ﹤0.01% | 1354 |
|
|
2020
Q1 | – | Sell |
-127,748
| Closed | -$10M | – | 1305 |
|
|
2019
Q4 | $11.1M | Buy |
+127,748
| New | +$10.5M | 0.06% | 337 |
|
|
2019
Q3 | – | Sell |
-11,753
| Closed | -$942K | – | 1415 |
|
|
2019
Q2 | $940K | Buy |
+11,753
| New | +$900K | 0.01% | 965 |
|
|
2018
Q4 | – | Sell |
-22
| Closed | -$1.55K | – | 1329 |
|
|
2018
Q3 | $1K | Sell |
22
-18,397
| -100% | -$1.17M | ﹤0.01% | 1280 |
|
|
2018
Q2 | $1.07M | Buy |
+18,419
| New | +$1.04M | 0.02% | 373 |
|
|
2017
Q4 | – | Sell |
-3,773
| Closed | -$230K | – | 598 |
|
|
2017
Q3 | $230K | Sell |
3,773
-49,526
| -93% | -$3M | 0.01% | 449 |
|
|
2017
Q2 | $3.26M | Buy |
53,299
+29,194
| +121% | +$1.78M | 0.09% | 193 |
|
|
2017
Q1 | $1.46M | Sell |
24,105
-67,916
| -74% | -$4.12M | 0.04% | 352 |
|
|
2016
Q4 | $5.17M | Buy |
+92,021
| New | +$5.39M | 0.16% | 125 |
|
|
2016
Q1 | – | Sell |
-15,386
| Closed | -$775K | – | 727 |
|
|
2015
Q4 | $775K | Buy |
+15,386
| New | +$776K | 0.02% | 280 |
|
|
2015
Q1 | – | Sell |
-119
| Closed | -$6K | – | 318 |
|
|
2014
Q4 | $6K | Sell |
119
-32,170
| -100% | -$1.79M | ﹤0.01% | 319 |
|
|
2014
Q3 | $1.83M | Sell |
32,289
-50,147
| -61% | -$2.82M | 0.02% | 299 |
|
|
2014
Q2 | $4.55M | Sell |
82,436
-53,044
| -39% | -$2.89M | 0.06% | 194 |
|
|
2014
Q1 | $7.34M | Buy |
135,480
+72,853
| +116% | +$3.77M | 0.09% | 138 |
|
|
2013
Q4 | $2.99M | Sell |
62,627
-147,000
| -70% | -$6.72M | 0.03% | 268 |
|
|
2013
Q3 | $9.52M | Buy |
+209,627
| New | +$9.57M | 0.1% | 116 |
|
Other funds holding MRK
VCM
VPM
Capstone Investment Advisors's MRK Position: Q1 2026 in Review
Capstone Investment Advisors reduced its Merck (MRK) stake by 80% in Q1 2026, selling an estimated $2.94M and leaving 6,472 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #953.
Capstone Investment Advisors first reported a position in MRK in Q3 2013 and has held it in 35 quarters since. The position peaked at $13.3M in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Capstone Investment Advisors held 6,472 shares of Merck worth $779K as of Q1 2026.
- Capstone Investment Advisors sold 25,432 Merck shares in Q1 2026, an estimated $2.94M.
- Merck made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #953 holding.
- Capstone Investment Advisors first reported a position in Merck in Q3 2013 and has held it in 35 quarters since.
- Capstone Investment Advisors's Merck position peaked at $13.3M in Q4 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.